Welcome!
Clearbridge Health
Healthcare
Healthcare stocks get a shot in the arm as Wuhan virus fears rise
Private outpatient medical service provider Healthway Medical Corporation led the way on Tuesday, surging 42.9% to a new 52-week-high of 4 cents as at 12pm. But other SGX-listed healthcare stocks are also on the rise.
January 21, 2020
Equity raising
Clearbridge Health in private placement to raise $11.3 mil to speed up Asia growth plans
SINGAPORE (July 29): Clearbridge Health is raising $11.34 million from a share placement exercise to accelerate its growth plans in Asia’s healthcare market.
July 29, 2019
M&A
Clearbridge acquires 89.6% stake in Indonesia's IGM Labs for $9.4 mil
SINGAPORE (Apr 3): Clearbridge Health is acquiring a 89.6% stake in IGM Labs of Indonesia for $9.4 million or 2.8 times its EV/EBITDA.
April 03, 2019
Healthcare
Clearbridge subsidiary to issue $2 mil in convertible bonds
SINGAPORE (Mar 25): Clearbridge Health Limited’s subsidiary, Clearbridge Biophotonics, is set to issue $2 million in convertible bonds to develop its proprietary computational imaging microscopy technology with the aim of commercialisation.
March 25, 2019
IPO
Biolidics shares slump on Catalist debut
SINGAPORE (Dec 19): Just two hours into its debut on the Singapore Exchange (SGX) Catalist board, shares in medical technology firm Biolidics have slumped 23.2% from its listing price of 28 cents.
December 19, 2018
IPO
Biolidics selling 27.5 mil new shares at 28 cents each in conjunction with Catalist listing
SINGAPORE (Dec 11): Medtech company Biolidics is selling 27.5 million new shares at 28 cents each to retail and institutional investors in a private placement ahead of its listing on the Catalist Board of the Singapore Exchange.
December 11, 2018
In print this week
Clearbridge Health rides on China's biotech boom for cancer diagnostic spinoff
SINGAPORE (Aug 31): Investors and foreign biotech veterans are making their way to China as the government aims to build a healthcare empire.
August 31, 2018
M&A
Clearbridge enters MoU for expansion of lab testing services to Indonesia
SINGAPORE (Aug 23): Clearbridge Health’s wholly-owned subsidiary, SAM Laboratory, is acquiring a controlling stake in PT Indo Genesis Medika, a company incorporated in Indonesia, for an aggregate consideration of about IDR 40.7 billion ($3.8 million).
August 23, 2018
IPO
Clearbridge BioMedics receives $6.6 mil in pre-IPO funding ahead of targeted 4Q launch
SINGAPORE (June 28): Clearbridge BioMedics has announced $6.6 million in pre-initial public offering (IPO) funding from oncology medical professionals, as well as investors focused in healthcare & biotechnology.
June 28, 2018
M&A
Clearbridge Health acquires 85% stake in medical aesthetics clinic for $5.5 mil
SINGAPORE (Apr 3): Clearbridge Health, the recently listed healthcare group, announced that it has completed its acquisition of an 85% stake in Medic Surgical Private Limited (MSPL) and Medic Laser Private Limited (MLPL) for $5.5 million.
April 03, 2018